Brevan Howard Capital Management’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.8K Sell
38,823
-5,790
-13% -$8.8K ﹤0.01% 2076
2025
Q4
$58.9K Sell
44,613
-224,915
-83% -$282K ﹤0.01% 1695
2025
Q3
$369K Buy
269,528
+233,911
+657% +$311K ﹤0.01% 1444
2025
Q2
$50.2K Sell
35,617
-89,782
-72% -$127K ﹤0.01% 1808
2025
Q1
$199K Buy
+125,399
New +$305K ﹤0.01% 989
2024
Q3
Sell
-75,143
Closed -$319K 1247
2024
Q2
$319K Buy
+75,143
New +$293K ﹤0.01% 754

Other funds holding GERN

Brevan Howard Capital Management's GERN Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Geron (GERN) stake by 13% in Q1 2026, selling an estimated $8.8K and leaving 38,823 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Brevan Howard Capital Management first reported a position in GERN in Q2 2024 and has held it in 6 quarters since. The position peaked at $369K in Q3 2025. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • Brevan Howard Capital Management held 38,823 shares of Geron worth $57.8K as of Q1 2026.
  • Brevan Howard Capital Management sold 5,790 Geron shares in Q1 2026, an estimated $8.8K.
  • Geron made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2076 holding.
  • Brevan Howard Capital Management first reported a position in Geron in Q2 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Geron position peaked at $369K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.